The future of the IVF lab: what “the laboratory of 2030” means for automation and AI
Published 12 November 2026 · IVF Automation · Lab operations and technology
The IVF lab of 2030 is likely to be more automated and more data-driven, not run by robots. The evidence so far supports automating quality control and workflow steps first. AI embryo selection and robotic ICSI are real but still early: a 2024 randomised trial could not show AI selection was non-inferior to embryologists, and the first robotic ICSI live birth, reported in 2025, still needed a remote human operator for about half the steps.
That gap between headline and evidence is exactly what the ASPIRE Embryology SIG has built a full-day course around. If you run a lab in India and are being pitched “AI-ready” everything, here is what the programme tells you to focus on, and what to wait for.
What is “The Laboratory of 2030” course at ASPIRE 2027?
It is Pre-Congress Course 1 at ASPIRE 2027, the 16th Congress of the Asia Pacific Initiative on Reproduction, held at PACIFICO Yokohama North, Japan, on 6 May 2027 (the congress runs 6–9 May). Organised by the ASPIRE Embryology SIG and chaired by Keshav Malhotra (India), it covers four blocks:
- The future of embryo culture: uninterrupted culture and continuous imaging, iPSC-derived support cells for in vitro maturation, and a panel on “evidence and hype” in new media additives.
- Engineering at the micron scale: new ICSI and biopsy tools, microfluidic sperm selection, automating continuous quality control, and automating the workflow “from dish preparation to discharge”.
- AI from promise to practice: where AI has earned its place and where it has not, AI embryo selection, and a debate on the motion “an AI agent can run the IVF laboratory”.
- Hands-on stations: oocyte and embryo grading AI software, microfluidic sperm preparation, micro-ICSI and micro-biopsy, DNA fragmentation, and automated ICSI and vitrification.
Registration for the course requires main-congress registration. We track it, with dates, on our IVF events calendar.
Which lab tasks are realistic to automate first?
Quality control and workflow tracking are the safest starting points, because they do not touch the embryo. Two of the course talks are about exactly this: continuous QC and end-to-end workflow automation. In practice that means:
- continuous logging of incubator temperature, gas and pH, with alarms that reach someone at 2 am;
- LN2 level and cryo-tank monitoring tied to an inventory, so every straw has a location and an owner;
- electronic witnessing and barcoded dish labelling at each handover;
- automatic KPI calculation (fertilisation, blastulation and similar rates) from data you already record.
The KPI piece already has a shared yardstick. The Vienna consensus (ESHRE and Alpha, Human Reproduction Open, 2017) defines laboratory performance and key performance indicators, so an automated dashboard can be built against an agreed standard rather than a vendor's own definitions. Our free KPI calculator and lab QC logs follow the same idea.
Where does AI embryo selection stand today?
Useful as a consistency and speed aid, but not proven better than trained embryologists. The largest randomised trial so far (Illingworth et al., Nature Medicine, 2024) randomised 1,066 patients across 14 clinics in Australia and Europe to embryo selection by a deep learning tool (iDAScore) or by standard morphology. Clinical pregnancy rates were 46.5% and 48.2%, and the trial could not demonstrate non-inferiority against its 5% margin.
That is why the ASPIRE session is titled “from what AI can do to what we should do”. For a lab manager, the practical questions are less about accuracy claims and more about governance: which version of the model is running, whether it was validated on a population like yours, who signs off the final decision, and how the score is recorded. Our guide to AI embryo assessment, FDA and CDSCO covers the regulatory side.
Can a robot perform ICSI yet?
In one reported case, yes, but with a human still in the loop. A 2025 case report in Reproductive BioMedicine Online described a digitally controlled, remotely operated ICSI system that automated the 23 micromanipulation steps of ICSI. Four of five donor oocytes fertilised, and one warmed blastocyst from the automated group led to a live birth. The system completed 49.6% of the steps autonomously; a remote operator handled the rest, and on-site staff were needed for set-up. Average injection time was just under 10 minutes per oocyte.
That is a feasibility milestone, not a product you can buy for a busy Indian lab next year. It is also why the course pairs automated ICSI with a debate rather than a sales pitch.
How should Indian labs judge new add-ons and “AI-ready” equipment?
Ask for the evidence grade first and the demo second. ESHRE's good practice recommendations on add-ons (Human Reproduction, 2023) review common add-ons, including time-lapse imaging and sperm selection techniques, and do not recommend most of them for routine use. A short buying checklist:
| Question | Why it matters |
|---|---|
| What peer-reviewed evidence exists, and is it randomised? | Separates validated tools from marketing |
| Can raw data be exported in an open format? | Avoids lock-in and lets you build your own KPIs |
| Who is accountable when the software and the embryologist disagree? | Keeps clinical responsibility clear |
| What service and AMC support exists in India? | Downtime in a lab costs cycles |
| Does it fit ART Act record-keeping? | Section 23 of the ART (Regulation) Act, 2021 requires records to be kept for at least ten years |
See also our vendor and AMC questions and AI in the IVF lab: India guide.
Frequently asked questions
When and where is ASPIRE 2027?
ASPIRE 2027 runs from 6 to 9 May 2027 at PACIFICO Yokohama North, Japan. “The Laboratory of 2030” is Pre-Congress Course 1 on Thursday 6 May.
Will AI replace embryologists by 2030?
Current evidence does not support that. The largest randomised trial of AI embryo selection could not show it was non-inferior to standard morphology, and the first robotic ICSI live birth still relied on a remote human operator.
What should an IVF lab automate first?
Start with tasks that do not touch the embryo: incubator and cryo-tank monitoring with alarms, electronic witnessing, inventory, and automatic KPI calculation against the Vienna consensus indicators.
Is microfluidic sperm selection proven?
ESHRE's 2023 add-ons recommendations review sperm selection techniques and do not recommend most add-ons for routine use. The ASPIRE course discusses microfluidic selection and DNA fragmentation as an open question.
Sources
- ASPIRE 2027. Pre-Congress Course 1: The Laboratory of 2030 and congress programme.
- Illingworth PJ et al. Deep learning versus manual morphology-based embryo selection in IVF: a randomized, double-blind noninferiority trial. Nature Medicine, 2024.
- Mendizabal-Ruiz G et al. A digitally controlled, remotely operated ICSI system: case report of the first live birth. Reproductive BioMedicine Online, 2025.
- ESHRE Add-ons Working Group. Good practice recommendations on add-ons in reproductive medicine. Human Reproduction, 2023.
- ESHRE Special Interest Group of Embryology and Alpha. The Vienna consensus: ART laboratory performance indicators. Human Reproduction Open, 2017.
- Government of India. The Assisted Reproductive Technology (Regulation) Act, 2021, section 23.
Your next step
Going to ASPIRE 2027 or another meeting this year? Plan it with our free IVF events calendar, which lists upcoming Indian and global fertility congresses with dates and official links.
General operational information only; not medical advice and no claim about clinical outcomes. Session details are as published by ASPIRE on 12 November 2026 and may change. See our disclaimer.